Fiduciary Trust CO Seagen Inc. Transaction History

Fiduciary Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	SELL	$187.64 - $206.25 $21,390 - $23,512	-114 Reduced 9.16%	1,130 $217,000
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $158,721 - $252,631	1,244 New	1,244 $251,000
Q2 2022 Aug 12, 2022	SELL	$108.81 - $179.33 $17,953 - $29,589	-165 Reduced 10.21%	1,451 $257,000
Q1 2022 May 12, 2022	BUY	$119.61 - $157.85 $193,289 - $255,085	1,616 New	1,616 $233,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

Stay updated on Fiduciary Trust CO with notifications on news.